<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35366881</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1746-6148</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>18</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>02</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMC veterinary research</Title>
          <ISOAbbreviation>BMC Vet Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Combined immunization with inactivated vaccine reduces the dose of live B. abortus A19 vaccine.</ArticleTitle>
        <Pagination>
          <StartPage>128</StartPage>
          <MedlinePgn>128</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">128</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12917-022-03229-0</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Brucella spp. is an important zoonotic pathogen responsible for brucellosis in humans and animals. Brucella abortus A19 strain is a widespread vaccine in China. However, it has a drawback of residual virulence in animals and humans.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In this study, the BALB/c mice were inoculated with either 100 μL PBS(control group, C group), 10<sup>9</sup> CFU/mL inactivated B. abortus A19 strain (I group), 10<sup>5</sup> CFU/mL (low-dose group, L group) 10<sup>6</sup> CFU/mL live B. abortus A19 strain (high-dose group, H group), or 10<sup>5</sup> CFU/mL live B. abortus A19 strain combined with 10<sup>9</sup> CFU/mL inactivated B. abortus A19 strain (LI group). Mice were challenged with B. abortus strain 2308 at 7 week post vaccination. Subsequently, the immune and protective efficacy of the vaccines were evaluated by measuring splenic bacterial burden, spleen weight, serum IgG, interferon-gamma (IFN-γ), interleukin-4 (IL-4) percentage of CD4 + and CD8 + T cells of mice via bacterial isolation, weighing, ELISA and flow cytometry, respectively.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The splenic bacterial burden and spleen weight of the mice in group LI were mostly equivalent to the mice of group H. Moreover, Brucella-specific serum IgG, IFN-γ, IL-4, and the percentage of CD4<sup>+</sup> and CD8<sup>+</sup> T cells of the LI group mice were similar to those of the H group. In the subsequent challenge test, both vaccines conferred protective immunity to wild-type (WT) 2308 strain. In addition, the levels of IL-4 and IFN-γ, CD4<sup>+</sup> and CD8<sup>+</sup> T cells in these mice were similar to those of the mice in the H group.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Combined immunization with low dose live vaccine and inactivated vaccine allowed to reduce the live B. abortus A19 vaccine, dose with an equivalent protection of the high-dose live vaccine.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Chuan-Yu</ForeName>
            <Initials>CY</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Livestock Infectious Diseases, Ministry of Education, Shenyang Agricultural University, Liaoning Province, 110866, Shenyang, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>TECON Biological Co., Ltd, 221 Lantian Road, 830000, Urumqi, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yu-Zhuo</ForeName>
            <Initials>YZ</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Livestock Infectious Diseases, Ministry of Education, Shenyang Agricultural University, Liaoning Province, 110866, Shenyang, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Meng-Zhi</ForeName>
            <Initials>MZ</Initials>
            <AffiliationInfo>
              <Affiliation>TECON Biological Co., Ltd, 221 Lantian Road, 830000, Urumqi, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Hai-Long</ForeName>
            <Initials>HL</Initials>
            <AffiliationInfo>
              <Affiliation>TECON Biological Co., Ltd, 221 Lantian Road, 830000, Urumqi, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ren</LastName>
            <ForeName>Li-Song</ForeName>
            <Initials>LS</Initials>
            <AffiliationInfo>
              <Affiliation>TECON Biological Co., Ltd, 221 Lantian Road, 830000, Urumqi, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Bao-Shan</ForeName>
            <Initials>BS</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Livestock Infectious Diseases, Ministry of Education, Shenyang Agricultural University, Liaoning Province, 110866, Shenyang, P. R. China. lbslgy@syau.edu.cn.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Animal Husbandry and Veterinary Medicine, Shenyang Agricultural University, 120 Dongling Road, Shenyang, 110166, China. lbslgy@syau.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Sun</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>TECON Biological Co., Ltd, 221 Lantian Road, 830000, Urumqi, P. R. China. hesun@tecon-bio.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Animal Husbandry and Veterinary Medicine, Shenyang Agricultural University, 120 Dongling Road, Shenyang, 110166, China. hesun@tecon-bio.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Ze-Liang</ForeName>
            <Initials>ZL</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Livestock Infectious Diseases, Ministry of Education, Shenyang Agricultural University, Liaoning Province, 110866, Shenyang, P. R. China. zeliangchen@yahoo.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Animal Husbandry and Veterinary Medicine, Shenyang Agricultural University, 120 Dongling Road, Shenyang, 110166, China. zeliangchen@yahoo.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMC Vet Res</MedlineTA>
        <NlmUniqueID>101249759</NlmUniqueID>
        <ISSNLinking>1746-6148</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002004">Brucella Vaccine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002004" MajorTopicYN="Y">Brucella Vaccine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName>
          <QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
          <QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Brucellosis</Keyword>
        <Keyword MajorTopicYN="N">Combined immunization</Keyword>
        <Keyword MajorTopicYN="N">Inactivated vaccine</Keyword>
        <Keyword MajorTopicYN="N">Live vaccine</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests in this section.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>3</Day>
          <Hour>20</Hour>
          <Minute>21</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35366881</ArticleId>
        <ArticleId IdType="pmc">PMC8976406</ArticleId>
        <ArticleId IdType="doi">10.1186/s12917-022-03229-0</ArticleId>
        <ArticleId IdType="pii">10.1186/s12917-022-03229-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Boschiroli ML, Foulongne V, O’Callaghan D. Brucellosis: a worldwide zoonosis. Curr Opin Microbiol. 2001;4(1):58–64. doi: 10.1016/S1369-5274(00)00165-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1369-5274(00)00165-X</ArticleId>
            <ArticleId IdType="pubmed">11173035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol. 2010;140(3–4):392–8. doi: 10.1016/j.vetmic.2009.06.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetmic.2009.06.021</ArticleId>
            <ArticleId IdType="pubmed">19604656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ficht TA. Intracellular survival of Brucella: defining the link with persistence. Vet Microbiol. 2003;92(3):213–23. doi: 10.1016/S0378-1135(02)00367-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0378-1135(02)00367-X</ArticleId>
            <ArticleId IdType="pubmed">12523983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schurig GG, Sriranganathan N, Corbel MJ. Brucellosis vaccines: past, present and future. Vet Microbiol. 2002;90(1–4):479–496. doi: 10.1016/S0378-1135(02)00255-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0378-1135(02)00255-9</ArticleId>
            <ArticleId IdType="pubmed">12414166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moriyón I, Grilló MJ, Monreal D, González D, Marín C, López-Goñi I, et al.  Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res. 2004;35(1):1–38. doi: 10.1051/vetres:2003037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1051/vetres:2003037</ArticleId>
            <ArticleId IdType="pubmed">15099501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lord VR, Schurig GG, Cherwonogrodzky JW, Marcano MJ, Melendez GE. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence. Am J Vet Res. 1998;59(8):1016–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9706206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stevens MG, Olsen SC. Antibody responses to Brucella abortus 2308 in cattle vaccinated with B. abortus RB51. Infect Immun. 1996;64(3):1030–4. doi: 10.1128/iai.64.3.1030-1034.1996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/iai.64.3.1030-1034.1996</ArticleId>
            <ArticleId IdType="pmc">PMC173875</ArticleId>
            <ArticleId IdType="pubmed">8641754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elzer PH, Enright FM, Colby L, Hagius SD, Walker JV, Fatemi MB, et al.  Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51. Am J Vet Res. 1998;59(12):1575–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9858409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mukherjee F, Jain J, Grilló MJ, Blasco JM, Nair M. Evaluation of Brucella abortus S19 vaccine strains by bacteriological tests, molecular analysis of ery loci and virulence in BALB/c mice. Biologicals. 2005;33(3):153–60. doi: 10.1016/j.biologicals.2005.04.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biologicals.2005.04.003</ArticleId>
            <ArticleId IdType="pubmed">16081301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schurig GG, Roop RM, Bagchi T, Boyle S, Buhrman D, Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol. 1991;28(2):171–88. doi: 10.1016/0378-1135(91)90091-S.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0378-1135(91)90091-S</ArticleId>
            <ArticleId IdType="pubmed">1908158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arenas-Gamboa AM, Ficht TA, Kahl-Mcdonagh MM, Gomez G, Rice-Ficht AC. The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle. Infect Immun. 2009;77(2):877–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2632017</ArticleId>
            <ArticleId IdType="pubmed">19047401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Z, Wang S, Zhang H, Xi L, Zhang J, Zhang X, et al.  Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant. Microb Pathog. 2018;124:250–7. doi: 10.1016/j.micpath.2018.08.052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.micpath.2018.08.052</ArticleId>
            <ArticleId IdType="pubmed">30149131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arenas-Gamboa AM, Rice-Ficht AC, Fan Y, Kahl-McDonagh MM, Ficht TA. Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-/- mouse model. Clin Vaccine Immunol. 2012;19(2):249–60. doi: 10.1128/CVI.05321-11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CVI.05321-11</ArticleId>
            <ArticleId IdType="pmc">PMC3272933</ArticleId>
            <ArticleId IdType="pubmed">22169089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsen SC. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle. Vet Ther. 2000;1(3):183–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19757581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lubroth J, Rweyemamu MM, Viljoen G, Diallo A, Dungu B, Amanfu W. Veterinary vaccines and their use in developing countries. Rev Sci Tech. 2007;26(1):179–201. doi: 10.20506/rst.26.1.1737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.20506/rst.26.1.1737</ArticleId>
            <ArticleId IdType="pubmed">17633302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berkelman RL. Human illness associated with use of veterinary vaccines. Clin Infect Dis. 2003;37(3):407–414. doi: 10.1086/375595.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/375595</ArticleId>
            <ArticleId IdType="pubmed">12884166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashford DA, di Pietra J, Lingappa J, Woods C, Noll H, Neville B, et al.  Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine. 2004;22(25–26):3435–3439. doi: 10.1016/j.vaccine.2004.02.041.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2004.02.041</ArticleId>
            <ArticleId IdType="pubmed">15308369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chand P, Chhabra R, Nagra J. Vaccination of adult animals with a reduced dose of Brucella abortus S19 vaccine to control brucellosis on dairy farms in endemic areas of India. Trop Anim Health Prod. 2015;47(1):29–35. doi: 10.1007/s11250-014-0678-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11250-014-0678-2</ArticleId>
            <ArticleId IdType="pubmed">25274621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aznar MN, Samartino LE, Humblet MF, Saegerman C. Bovine brucellosis in Argentina and bordering countries: update. Transbound Emerg Dis. 2014;61(2):121–133. doi: 10.1111/tbed.12018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/tbed.12018</ArticleId>
            <ArticleId IdType="pubmed">23046031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beckett FW, MacDiarmid SC. The effect of reduced-dose Brucella abortus strain 19 vaccination in accredited dairy herds. Br Vet J. 1985;141(5):507–14. doi: 10.1016/0007-1935(85)90046-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0007-1935(85)90046-6</ArticleId>
            <ArticleId IdType="pubmed">4063777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osman AE, Hassan AN, Ali AE, Abdoel TH, Smits HL. Brucella melitensis biovar 1 and brucella abortus S19 vaccine strain infections in milkers working at cattle farms in the Khartoum Area Sudan. PLoS One. 2015;10(5):e0123374–0123374. doi: 10.1371/journal.pone.0123374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0123374</ArticleId>
            <ArticleId IdType="pmc">PMC4418725</ArticleId>
            <ArticleId IdType="pubmed">25938483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baoshan L, Yinbo Y, Jingbo Z, Yi Z, Jianghua Y, Dawei C, et al. Combined nucleic acid assays for diagnosis of A19 vaccine-caused human brucellosis. Transbound Emerg Dis. 2021;68(2):368–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32543112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hongzhuan Z, Ying T, Xia S, Jinsong G, Zhenhua Z, Beiyu J, et al.  Preparation of the inactivated Newcastle disease vaccine by plasma activated water and evaluation of its protection efficacy. Appl Microbiol Biotechnol. 2020;104(1):107–117. doi: 10.1007/s00253-019-10106-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00253-019-10106-8</ArticleId>
            <ArticleId IdType="pmc">PMC6942578</ArticleId>
            <ArticleId IdType="pubmed">31734810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ugalde JE, Comerci DJ, Leguizamón MS, Ugalde RA. Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine. Infect Immun. 2003;71(11):6264–9. doi: 10.1128/IAI.71.11.6264-6269.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.71.11.6264-6269.2003</ArticleId>
            <ArticleId IdType="pmc">PMC219583</ArticleId>
            <ArticleId IdType="pubmed">14573645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu W, Weigand L, Mendez S. The IL-6-deficient mouse exhibits impaired lymphocytic responses to a vaccine combining live Leishmania major and CpG oligodeoxynucleotides. Can J Microbiol. 2009;55(6):705–713. doi: 10.1139/W09-017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1139/W09-017</ArticleId>
            <ArticleId IdType="pmc">PMC2774832</ArticleId>
            <ArticleId IdType="pubmed">19767842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Golding B, Scott DE, Scharf O, Huang LY, Zaitseva M, Lapham C, et al.  Immunity and protection against Brucella abortus. Microbes Infect. 2001;3(1):43–8. doi: 10.1016/S1286-4579(00)01350-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1286-4579(00)01350-2</ArticleId>
            <ArticleId IdType="pubmed">11226853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Street NE, Schumacher JH, Fong TA, Bass H, Fiorentino DF, Leverah JA, et al.  Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol. 1990;144(5):1629–39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1968485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliveira SC, Zhu Y, Splitter GA. Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells. Immunology. 1994;83(4):659–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1415073</ArticleId>
            <ArticleId IdType="pubmed">7875746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy EA, Sathiyaseelan J, Parent MA, Zou B, Baldwin CL. Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology. 2001;103(4):511–8. doi: 10.1046/j.1365-2567.2001.01258.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2567.2001.01258.x</ArticleId>
            <ArticleId IdType="pmc">PMC1783270</ArticleId>
            <ArticleId IdType="pubmed">11529943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vitry MA, De Trez C, Goriely S, Dumoutier L, Akira S, Ryffel B, et al.  Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice. Infect Immun. 2012;80(12):4271–80. doi: 10.1128/IAI.00761-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00761-12</ArticleId>
            <ArticleId IdType="pmc">PMC3497404</ArticleId>
            <ArticleId IdType="pubmed">23006848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Macedo GC, Magnani DM, Carvalho NB, Bruna-Romero O, Gazzinelli RT, Oliveira SC. Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection. J Immunol. 2008;180(2):1080–1087. doi: 10.4049/jimmunol.180.2.1080.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.180.2.1080</ArticleId>
            <ArticleId IdType="pubmed">18178848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yingst SL, Izadjoo M, Hoover DL. CD8 knockout mice are protected from challenge by vaccination with WR201, a live attenuated mutant of Brucella melitensis. Clin Dev Immunol. 2013;2013:686919–686919. doi: 10.1155/2013/686919.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/686919</ArticleId>
            <ArticleId IdType="pmc">PMC3830850</ArticleId>
            <ArticleId IdType="pubmed">24288554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang X, Becker T, Walters N, Pascual DW. Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge. Infect Immun. 2006;74(7):3874–9. doi: 10.1128/IAI.01957-05.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01957-05</ArticleId>
            <ArticleId IdType="pmc">PMC1489696</ArticleId>
            <ArticleId IdType="pubmed">16790759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim HS, Caswell CC, Foreman R, Roop RM, Crosson S. The Brucella abortus general stress response system regulates chronic mammalian infection and is controlled by phosphorylation and proteolysis. J Biol Chem. 2013;288(19):13906–16. doi: 10.1074/jbc.M113.459305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M113.459305</ArticleId>
            <ArticleId IdType="pmc">PMC3650426</ArticleId>
            <ArticleId IdType="pubmed">23546883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willett JW, Herrou J, Briegel A, Rotskoff G, Crosson S. Structural asymmetry in a conserved signaling system that regulates division, replication, and virulence of an intracellular pathogen. Proc Natl Acad Sci U S A. 2015;112(28):E3709–E3718. doi: 10.1073/pnas.1503118112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1503118112</ArticleId>
            <ArticleId IdType="pmc">PMC4507200</ArticleId>
            <ArticleId IdType="pubmed">26124143</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
